Purpose: To investigate the lung tissue response measured with computed tomography (CT) after radiotherapy (RT) combined with metoclopramide. Patients and Methods: Patients with non-small cell lung cancer (tumor stage IIIA and IIIB), included in a multicenter, randomized phase III trial investigating the use of metoclopramide as a radiosensitizing agent, were examined with repetitive post-RT CT scans. The analysis comprised data up to 100 days after RT for a subgroup of 16 patients treated with a total dose of 60 Gy given in 1.82 Gy per fraction. Results: Large radiation doses to subvolumes were associated with denser lung tissue measured with CT (p < 0.001). Opposed to this finding, the volume of lung tissue irradiated with significant doses (V 40Gy ) was negatively correlated with the average increase in lung tissue density (p = 0.003). Patients randomized to metoclopramide injections also experienced less increase in lung tissue density (p = 0.01).
Introduction
In patients with localized, inoperable non-small cell lung cancer (NSCLC), radical radiotherapy (RT) is the treatment of choice. Since radical RT may be limited by consequential pneumonitis and lung fibrosis, a better understanding of the relationship between the radiation dose and the development of late side effects is needed [3, 4, 12, 17] . Previous studies have established computed tomography (CT) as a tool to monitor the development of fibrosis/pneumonitis measured as changes in CT density [9, 10, 19] . Dose-effect relationships have been derived for breast cancer and lymphoma patients [1, 18] , and for patients with lung cancer [13, 15] . There are less detailed data describing the time dependency of the density changes after RT (post-RT) [14, 16] . Some authors have chosen to investigate populations of breast cancer and lymphoma patients, partially because of the well-known obstacles related to investigations of late side effects in lung cancer patients [2, 18] : First, the survival of lung cancer patients is low, and consequently, the patient materials are of low figures, and may thus be highly selected. Second, the lung function is influenced not only by RT, but also by tumor progression and other lung diseases frequently present in these patients. Nevertheless, certainly also for this patient group, further investigations on post-RT side effects are justified.
The enzyme adenosine diphosphate ribosyl transferase is activated by DNA-damaging agents. From in vitro studies, metoclopramide has been shown to inhibit this enzyme resulting in increased cytotoxic effect of radiation and chemotherapeutic drugs [6, 11] . A phase I/II study indicated that metoclopramide could be used safely as a radiosensitizer and that the drug could have positive treatment effects [8] .
In this retrospective study, the results from an analysis on our institution's follow-up data from a multicenter, randomized phase III study are presented. The primary goal of the multicenter study was to explore the overall survival effect of metoclopramide as a radiosensitizer in the treatment of NSCLC [8] . The present paper concentrates on the influence of the radiosensitizer and RT on normal lung tissue measured as CT density changes.
Patients and Methods
During 1995-1998, 30 NSCLC patients from our institution were enrolled in a multicenter, randomized phase III study aimed at investigating the efficacy, safety and tolerability of intramuscular injections of neutralized metoclopramide 100 mg/ml (Neu-Sensamide™) as a radiosensitizing agent [6] . Neu-Sensamide™ was produced by Oxigene Europe AB.
Inclusion criteria were inoperable NSCLC, squamous cell carcinoma, stage IIIA and IIIB, age > 30 years and Karnofsky Performance Scale ≥ 80. The local ethics committee approved the protocol, and all participating patients gave informed consent before entering the study. All available follow-up data were transferred to the central study group at Oxigene Europe AB in Lund, Sweden, for later analysis and publication.
The multicenter study was closed prematurely due to financial matters. No follow-up data have been published from the central study group.
16 of the 30 patients from our hospital had sufficient data for a local analysis, i.e., complete RT records and CT examinations. Three of the 16 patients were female and the median age was 68 years (range 46-81 years). The remaining 14 patients had insufficient follow-up data (partly because of withdrawal from the study related to rapid disease progression during or shortly after RT and partly because of inadequate RT files).
Radiosensitizer
Seven patients were randomized to receive intramuscular injections of neutralized metoclopramide, 2 mg/kg given 1 h prior to RT, three times per week. Four patients complied with the protocol, one patient was not given the sensitizer the last week, and two patients refused to continue with the sensitizer after few injections due to side effects (fatigue, muscle pain, headache, and indigestion).
Radiotherapy
All patients were given megavoltage (6-15 MV) conformal RT applying two to four, usually three, radiation fields. The ICRU central axis dose was 60 Gy given in 1.82 Gy per fraction 5 days per week. The RT dose planning was performed with Treatment Management System v3.1 (Helax) based on CT scans acquired with 10 mm slice thickness and 10 mm distance between the slices. The clinical target volume comprised the gross tumor volume (GTV) plus a 10 mm margin accounting for subclinical disease. The multileaf collimators were set to obtain an additional margin of minimum 5-10 mm, and normally 20 mm to account for setup errors and penumbra. Dose volume histograms (DVH) of both lungs as a single organ, and only the affected lung excluding the GTV were calculated. All doses presented in this study have been corrected according to the linear quadratic formula with α/β = 3 Gy for late side effects and dose per fraction = 2 Gy [7] .
Follow-Up CT Scans
For each patient, follow-up CT scans were intended to be performed 12 and 16 weeks after the start of RT (i.e., approximately 35 and 65 days after the end of RT lasting 6.5 weeks). In addition, several patients had extra diagnostic post-RT CT scans related to suspected tumor progression. After advice from our statistician (D.T.K.), we chose to set a cut off at 100 days when plotting the data and 90 days for the statistical analysis. A median number of 2.5 CT examinations per patient were available (Table 1) . CT scans were performed with Cytec 3000 (General Electrics) in a private radiology clinic. The Cytec 3000 was a sequential CT scanner. Normally, the slice thickness was 5 mm.
We chose to present radiation-induced alterations in lung tissue density as changes in the air-filled fraction (f air ) according to [18] :
where ρ is the electron density relative to water and NCT is the measured CT number in Hounsfield Units. The advantage of f air is that the relative effect seldom attains values > 100% in contrast to the relative change in tissue density, ρ [18] . Volumes of interest (VOIs) for CT number measurements were defined on the RT planning computer. VOIs identified normal lung tissue in regions of homogeneous dose close to the tumor and were delineated on three adjacent CT slices with the middle slice containing the ICRU central axis dose. VOIs corresponding to regions covered by either one or several RT fields were chosen for each patient (Figure 1 ). The VOI size was typically 30-100 cm 3 . The 2 Gy equivalent mean dose and the VOI's location -anterior, central, or posterior -were recorded. The standard deviation (SD) of the VOI dose distribution was always < 10%. A median number of three VOIs for each patient were defined (Table 1) .
Hard-copy RT planning CT images of the VOI were compared with post-RT CT images. Corresponding CT images were identified by visually comparing bony and soft-tissue anatomy, and the VOI could thus be digitally delineated on post-RT CT images. The overall mean CT number of the VOI was obtained from multiple small circular areas covering the VOI (Figure 1) .
Ideally, the f air obtained after RT should have been normalized according to the individual's baseline value obtained prior to RT (pre-RT). Unfortunately, it was not possible to obtain the baseline CT numbers from the images in the RT planning system. Therefore, the f air was normalized according to a global f air of 0.802, the mean f air from all lung VOIs receiving a radiation dose < 8 Gy. To investigate the uncertainty of this normalization procedure, data from the Netherlands Cancer Institute were used. These data included f air of lowdose (< 8 Gy) areas of the lung from both pre-RT CT scans and 3-4 months post-RT. Thus, the ideal normalization method could be compared with the method applied in the present study. The uncertainty introduced by not having access to the baseline f air is measured to be 4% (R 2 = 0.96; Figure 2 ).
Statistical Analysis
To evaluate the reduction in f air , the measurement times were pooled: within 30 days, 31-60 days and 61-90 days after the end of RT. A repeated measurement analysis of variance was undertaken using the highest radiation dose (> 40 Gy) to the VOI for each time interval, whether radiosensitizer dose was administered or not, CT post-RT examination time, and VOI location (central, anterior, posterior) as explanatory variables.
p-values from two-sided tests are presented, and should be considered hypothesis-generating as no power calculations had been performed for the comparisons reported in this paper. The data were analyzed with SPSS v10.1.0 and SAS v.9.1.3. 
Results
The impact of the radiosensitizer and the radiation dose to the course of the f air , has been visualized in plots for each patient according to whether the patient received radiosensitizer or not. The reduction in f air increased with radiation dose (p < 0.001), and the effect was more pronounced for those patients not given metoclopramide (p = 0.01; Figure 3 ). The normal lung volume (both lungs delineated) irradiated with significant radiation doses (20-60 Gy) was negatively correlated with the reduction in f air . The most significant parameter was V 40Gy (p = 0.003; Figure 4 ). The time dependence of f air was analyzed using an interaction variable; time and whether metoclopramide was given or not. The reduction in f air increased with the time interaction variable (p = 0.04; Figure 5 ). There was a larger reduction in f air for those VOIs located in the posterior position in the lung (p = 0.01). There was no significant difference in f air values comparing the central with the anterior position (p = 0.17).
Discussion
In the present study, we found that the density change (ρ) in the lung, measured as an air-filled fraction (f air = 1 -ρ) change, was dependent on radiation dose. Normal lung tissue irradiat- ed with > 30 Gy was denser 50-100 days after treatment compared to tissue irradiated with smaller doses (Figure 3a) . This has also been demonstrated in previous studies. Theuws et al. [18] found that the effect measured as a relative change in f air attained values significantly different from zero for doses > 20 Gy. Their results were derived from a material of lymphoma and breast cancer patients but were also confirmed in a study by Seppenwoolde et al. for NSCLC patients [15] . In a study by Boersma et al., the dose-effect relation increased from zero effect at approximately 30 Gy [1] . Rosen et al. found a threshold for physician-identified radiographic fibrosis at 30-35 Gy, but significant density changes were also detected for smaller doses [13] .
Opposed to the positive correlation between local radiation dose to smaller lung volumes, there was a negative correlation between the normal lung volumes irradiated with significant doses (V 40Gy ) and the reduction in f air . A possible explanation is an antitumor effect of the RT making the conditions for the normal lung tissue more favorable.
The CT examinations were performed at various time points after RT but due to the limited patient number, an exact quantification of the relationship between reduction in f air and time was not possible. Skoczylas et al. [16] measured a change in optical density on follow-up X-rays of breast cancer patients treated with RT. These investigators found a monotonous increase in effect from 1 month reaching a plateau at 4-5 months and then decreasing moderately at 8-10 months. These findings are in agreement with a CT study by Rotstein et al., examining breast cancer patients at 3 and 9 months after RT [14] .
The decrease in f air was significantly larger for the posterior third of the lung. All patients were examined and treated in the supine position. Theuws et al. have demonstrated this effect previously [18] . Their explanation was a gravity-dependent density gradient causing a relative increase in lung mass (edema) in the posterior region after irradiation.
There was a statistically significant association between high doses of metoclopramide, and the least reductions in f air . Animal experiments have reported no increase in effects on normal tissue when combining RT with metoclopramide [11] . A possible explanation for the relationship between metoclopramide dose and f air is an antitumor effect similar to the negative correlation between normal lung volumes encompassed by the 40 Gy isodose (V 40Gy ) and the reduction in f air . The tumors were mostly centrally located (stage IIIA and IIIB), and the patients enduring the drug treatment, could get increased blood perfusion and airflow to the neighboring normal tissues in the lung. These effects of tumor shrinkage have been shown by De Jaeger et al. and Seppenwoolde et al. [5, 15] . The resulting improved physiological conditions after RT could make the lung tissue more resistant to development of fibrosis/pneumonitis. Tumor volumes before and after RT could have elucidated our data further. Regrettably, tumor volumes were not available in the present material.
Conclusion
There was an increase in the density of lung tissue with radiation dose and time after RT. This effect was more pronounced for the posterior lung volumes. Metoclopramide and irradiation of large lung volumes with significant doses seemed to protect against fibrosis/pneumonitis development. However, the number of patients in the analysis was low. Therefore, the results must be interpreted with caution.
